Cancer Immunology, Immunotherapy

Published by: Springer  

Groups

  1. Department of Medicine (36)
  2. Solid Tumor Oncology Division (26)
  3. Melanoma Disease Management Team (23)
  4. Melanoma and Immunotherapeutics Service (20)
  5. GSK Faculty (17)
  6. Sloan Kettering Institute Faculty (15)
  7. Hematologic Malignancies, Division of (14)
  8. Molecular Pharmacology and Chemistry Program Faculty (12)
  9. Tow Center for Developmental Oncology (TCDO) (11)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (10)
Search Within
Groups
  1. Department of Medicine (36)
  2. Solid Tumor Oncology Division (26)
  3. Melanoma Disease Management Team (23)
  4. Melanoma and Immunotherapeutics Service (20)
  5. GSK Faculty (17)
  6. Sloan Kettering Institute Faculty (15)

More Groups

People
  1. Philip Livingston (18)
  2. Govindaswami Ragupathi (15)
  3. Kenneth Lloyd (6)
  4. Lloyd Old (6)
  5. Achim Jungbluth (5)
  6. David Scheinberg (5)

More People

Publishers
  1. Springer (78)

Results (78)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cancer Immunology, Immunotherapy – authorized name for:

    Name ISSN / ISBN Publisher
    Cancer Immunology and Immunotherapy 978-3-642-14136-2 Springer Verlag
    Cancer Immunology Immunotherapy 0340-7004 Springer
    Cancer Immunology Immunotherapy 0340-7004 Unknown
    Cancer Immunology Immunotherapy 0340-7004 Springer
    Cancer Immunology Immunotherapy 0340-7004 Springer
    Cancer Immunology Immunotherapy 0340-7004 Springer Verlag
    Cancer Immunology Immunotherapy 03407004 Springer Verlag
    Cancer Immunology Immunotherapy 03407004 Unknown
    Cancer Immunology Immunotherapy 0340-7004 Springer Verlag
    Cancer Immunology, Immunotherapy 0340-7004 Springer Verlag
    Cancer Immunology, Immunotherapy 0340-7004 Springer Verlag
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 03407004 2022, The Author(s), Under Exclusive Licence To Springer Verlag Gmbh Germany, Part of Springer Nature
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 03407004 2018, Springer Verlag Gmbh Germany, Part of Springer Nature
    Cancer Immunology, Immunotherapy 03407004 2019, The Author(s)
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 03407004 The Author(s)
    Cancer Immunology, Immunotherapy 03407004 2022, The Author(s)
    Cancer Immunology, Immunotherapy 03407004 2023, The Author(s)
    Cancer Immunology, Immunotherapy 03407004 2023, The Author(s), Under Exclusive Licence To Springer Verlag Gmbh Germany, Part of Springer Nature
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag Berlin Heidelberg
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag Berlin Heidelberg
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 03407004 Springer Verlag
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 0340-7004 Springer
    Cancer Immunology, Immunotherapy 03407004 Unknown
    Cancer Immunology, Immunotherapy 03407004 Us Government